In Canada, key partnerships and collaborations across the isotope supply chain have fostered innovation, encouraging new approaches and technology to produce emerging isotopes.

Ensuring equal access to radiopharmaceuticals and diagnostic scans, in addition to effectively incorporating radiotheranostics into cancer care, requires transdisciplinary collaboration between radiation oncologists, nuclear medicine physicians and technologists, radiologists, radiation and imaging scientists, along with dedicated infrastructure and a specialized supply chain. While Canada does possess much talent in this space, innovative models of care, infrastructure, and patient partnerships are needed to translate this exciting science into access to care and improved survival from cancer.